Hence, the aim of the current study was to explore whether B7-H3 regulated cellular senescence and growth arrest in CRC cells treated with a low dose of DOX in an attempt to optimize chemotherapy-induced senescence therapies associated with B7-H3. The gene discussed is CD276; the disease is colorectal carcinoma.